Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)

NCT04483167 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Atherosclerosis

Interventions

DRUG: 99mTccAbVCAM1-5 injection

Sponsor

University Hospital, Grenoble